The apparent difference in tumour spectrum between carriers of the POLE p.Leu424Val and the POLD1 p.Ser478Asn substitutions was unexplained and the authors mention that similar differences are found in Lynch syndrome where endometrial cancer seems to be more frequent in carriers of MSH6 mutations. Here, MSH6 is linked to endometrial cancer.